Novo Nordisk buys Akero Therapeutics in the US
RefinitivMeno di 1 minuto di lettura
Danish drugmaker Novo Nordisk 
NOVO_B said on Thursday it had agreed to buy United States based Akero Therapeutics, a clinical-stage company developing innovative treatments for patients with serious metabolic diseases marked by a high unmet medical need.
Accedi o crea un account gratuito per leggere queste notizie